fda glp-1 compounding warning october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Today, the FDA is announcing

13 You must wait for approval, wait for the inevitable shortage (because demand always exceeds supply), and then move with precision

This percentage increases to 40% among those who intend to take the drug in the future

Take body measurements during stalls, because body composition changes (fat loss plus muscle preservation) often continue even when scale weight is static

Clinical services, including medical consultations and prescribing decisions, are provided by independent, licensed healthcare providers who exercise their own professional judgment

Wilding JP, et al

Hadidchi is supported every step of the way from initial evaluation and treatment selection to follow-ups and motivation throughout your wellness path